在前性THYMOGENE试验中鉴定出甲状腺上皮瘤的体质突变
Eleonora Pardini1, Federico Cucchiara2, Serena Barachini3
1Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
Thoracic cancer
|December 17, 2025
概括
在GTF2I中的基因突变驱动许多胸膜上皮瘤. 然而,GTF2I野生型瘤的遗传原因在很大程度上仍然未知,这对诊断和治疗构成了挑战.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 胸膜上皮瘤 (TETs) 具有部分理解的分子基础.
- GTF2I突变涉及大约50%的TET病原体.
- 其余TET病例的分子驱动因素在很大程度上是未知的.
研究的目的:
- 为了研究胸膜上皮瘤的分子格局.
- 确定TETs中的关键遗传异常,特别是GTF2I野生型病例.
主要方法:
- 在Thymogene试验中,从70名患者的瘤和正常DNA的前性测序.
- 利用基因小组针对TETs中经常发生突变的基因.
- 在19个瘤样本中用于瘤细胞隔离的流细胞计.
主要成果:
- GTF2I突变是最常见的 (41%),与特定的胸腺瘤类型和早期阶段相关.
- 相互排斥和同时发生的突变模式表明了不同的致病途径.
- 在77个评估基因中,在39%的患者中没有检测到任何突变.
- 特定的突变特征 (COSMIC 1, 19, 25) 被丰富,可能与除毒或化疗有关.
结论:
- GTF2I突变是TET子集中的重要驱动因素,有时与突变同时发生.
- 许多GTF2I野生型TET缺乏常见的体质突变,表明难以捉摸的基因组异常.
- 在GTF2I野生型TET中发现突变仍然具有挑战性,即使使用专门的测序工具.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


